Before you approve that note, see what it's really doing.
Send us the term sheet and we'll tell you what it's really worth, what it costs, and whether a simpler structure does the job. For the family offices and institutions we work with, that first review is usually the start of a standing analytics relationship.
Access is solved. Judgment is not.
A term sheet gives you the terms. A review gives you the judgment, starting with four questions it can't answer on its own.
What is it really doing?
The option components you're actually long and short, past the marketing name.
What does it cost?
The embedded margin built into par on day one, separated out.
Where does it break?
The paths and barriers where the payoff turns against you.
Is there a cleaner alternative?
Whether simpler, liquid instruments reach the same goal for less.
And how it would sit in the book you already hold: overlap with risk you carry, concentration, and its contribution to a bad-case drawdown. Portfolio-level work draws on our scenario stress-testing and hedging practice.
Modeled, not eyeballed.
We break the note into its building blocks and price each on a governed engine built in-house. The numbers come from the model, not an opinion.
Autocallable Yield Note
“A contingent coupon on the worst of two indices, with a 65% barrier and quarterly autocall.”
- Coupon: Contingent, paid quarterly
- Barrier: 65% of initial level
- Maturity: Autocallable quarterly
- Long zero-coupon bond
Issuer credit risk; worth less than par at outset.
- Short down-and-in put
You sold the crash protection at the 65% barrier.
- Short autocall option
Your upside is capped; the issuer controls the call.
- Embedded cost
Issuer margin and costs built into the price.
We review the full range: autocallables, reverse convertibles, buffer and barrier notes, principal-protected and participation structures, and digitals, on single names, baskets, and indices.
A memo that decides the question.
A focused review that turns the term sheet into a decision. Enter your email to see a real one our engine produced on an illustrative note.
See a sample review
Enter your email to view a full review our engine produced on an illustrative note. It's the same analytics you'd get on your own.
We’ll only use it to follow up, and you can unsubscribe anytime. See our privacy policy.
A preview of real output from our review engine on an illustrative note (terms composited from comparable issuance, not a live offering). 12,000 Monte Carlo paths; every figure traces to a reproducible run. Shown as a preliminary estimate, not a paid-final model value, and not investment advice. A live review prices the actual issuer term sheet.
Every review: a plain-English summary, the decomposition, an estimated value and embedded cost, the outcome odds, a comparison to simpler alternatives, and a bottom-line read, scored on six dimensions (objective fit, value, downside clarity, liquidity, complexity, and alternatives).
An exotic structured-product trader, on your side.
Julian Lippa
Founder, Verio Labs
“I priced and traded these structures for years. I know exactly how they're built, and what they're really worth.”
Twelve years trading and pricing exotic options and structured products on a tier-one desk, the kind that designs, hedges, and prices these notes. The engine behind every review is built in-house, and every review is signed off by that experience.
More about the backgroundFrom one review to a standing desk.
Most engagements start with a single note. For the family offices and institutions we work with, that review is the on-ramp to a standing relationship: an independent analytics desk your own team can lean on, without adding headcount.
A single review
Send one term sheet with your objective and constraints. We decompose and price it, every assumption documented, and return a clear memo, usually in a few business days. We scope before we quote, and there's no commitment to start.
A retained desk
Ongoing reviews, comparison work, and pre-trade structuring on call, with a shared archive and priority turnaround. Your independent structured-products and derivatives bench, retained, so the analysis is there before the next decision, not after.
Supplemental input only
Built for family offices, institutions, and the advisers and investment teams that serve them. We're not a law firm, compliance consultant, registered investment adviser, or broker-dealer; our analysis supports your own process and decisions, it doesn't replace them, and you remain responsible for them.
Independent, with nothing to sell.
- No issuer compensation. No products to sell. No commissions.
- We don't custody assets and we don't execute trades. The analysis is the deliverable.
- Independent analytics and decision support. We don't replace your fiduciary, compliance, legal, or tax advice; the investment decision stays yours.
Verio Labs is not a registered investment adviser, broker-dealer, or placement agent. A review is educational and analytical decision support, not a recommendation to buy or sell any security. See our disclosures.
Common questions.
What do you need from me?
The term sheet, indicative or final, plus your objective, position size, and any constraints.
How fast is it?
A few business days. Rush turnaround when a decision can't wait.
Can you review a note I already own?
Yes. A review is just as useful after purchase, for monitoring, a hold-or-exit call, or documentation.
Do you contact the issuer?
No. The review is independent, based on the term sheet and market data.
Is this investment advice?
No. It's independent analytical and educational decision support. The decision stays with you and your own advisers.